All News Ipsen S.A. OTC Markets

Equities

IPSEY

US4626292050

Market Closed - OTC Markets Other stock markets 02:41:09 2024-07-17 pm EDT			5-day change	1st Jan Change
30.38 ^USD	-0.26%		+2.38%	+3.05%

Jul. 11	CAC40: maintains gains after reassuring US inflation figures	CF
Jul. 11	CAC40: rise without volume, W-Street at its zenith but falls back	CF

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

IPSEN : Buy back programme Art 5 of MAR Week 28 2024	Jul. 16	PU
IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2024	Jul. 16	GL
CAC40: maintains gains after reassuring US inflation figures	Jul. 11	CF
CAC40: rise without volume, W-Street at its zenith but falls back	Jul. 11	CF
CAC40: over 7600pts before US inflation figures	Jul. 11	CF
Ipsen: worldwide licensing agreement with Foreseen	Jul. 11	CF
Ipsen, Foreseen Biotechnology Ink Exclusive Global Licensing Deal for Antibody-drug Conjugate	Jul. 11	MT
Ipsen : and Foreseen Biotechnology announce exclusive global licensing agreement for antibody drug conjugate with first in class potential	Jul. 11	PU
Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class potential	Jul. 11	GL
Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class potential	Jul. 11	AQ
Markets Powered by Alternating Current	Jul. 10
IPSEN : Buy back programme Art 5 of MAR Week 27 2024	Jul. 09	PU
IPSEN - Buy-back programme - Art 5 of MAR - Week 27 - 2024	Jul. 09	GL
Ipsen : Half year statement of IPSEN liquidity agreement 2024 06 30	Jul. 08	PU
Half-year statement of IPSEN liquidity agreement - 2024 06 30	Jul. 08	GL
Half-year statement of IPSEN liquidity agreement - 2024 06 30	Jul. 08	AQ
Hutchmed Shares Rise After Tazemetostat Gets Priority Review Status in China	Jul. 05	MT
IPSEN : Buy back programme Art 5 of MAR Week 26 2024	Jul. 02	PU
IPSEN - Buy-back programme - Art 5 of MAR - Week 26 - 2024	Jul. 02	GL
Ipsen Expands Partnership with Exelixis for Cabometyx	Jul. 02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

IPSEN : Better-than-expected Q1; guidance unchanged

April 24, 2024 at 10:50 am EDT